Editorial: Managing cancer metastasis by tackling anticancer drug resistance.

Wu, Erxi; Wu, Zhongzhi; Yang, Chao-Yie; Qi, Dan; Hu, Xiaoxiao; Li, Wei

Wu, Erxi; Wu, Zhongzhi; Yang, Chao-Yie; Qi, Dan; Hu, Xiaoxiao; Li, Wei.

Affiliation

Wu E; Department of Neurosurgery and Neuroscience Institute, Baylor Scott & White Health, Temple, TX, United States.
Wu Z; Department of Neurosurgery, Baylor College of Medicine, Temple, TX, United States.
Yang CY; School of Medicine, Texas A&M University, College Station, TX, United States.
Qi D; Irma Lerma Rangel School of Pharmacy, Texas A&M University, College Station, TX, United States.
Hu X; LIVESTRONG Cancer Institutes and Department of Oncology, Dell Medical School, The University of Texas at Austin, Austin, TX, United States.
Li W; Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN, United States.

Front Pharmacol ; 15: 1432248, 2024.

Article de En | MEDLINE | ID: mdl-38915467

Mots clés

anti-cancer agents; cancer treatment; drug resistance; metastasis; resistance mechanisms; therapeutic strategies

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Front Pharmacol Année: 2024 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Suisse

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google